Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer
Clinical trial NCT01436214 · UNKNOWN
Trial details
- NCT number
- NCT01436214
- Sponsor
- Adamis Pharmaceuticals Corporation
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2016-08-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.